BOSTON -- Carvedilol (Coreg, Coreg CR) helped to mitigate cardiac risk in patients undergoing pheochromocytoma surgery, researchers reported here. In a comparison of several blood pressure (BP) ...

Please provide your email address to receive an email when new articles are posted on . Two preparations of carvedilol given to patients with heart failure were found nearly bioequivalent. Researchers ...

November 17, 2006 — The US Food and Drug Administration (FDA) has approved safety labeling revisions to advise on the use of carvedilol tablets in diabetic patients; the risk for potentially fatal ...

Mar. 23 -- WEDNESDAY, Sept. 5 (HealthDay News) -- The U.S. Food and Drug Administration has approved the first generic versions of Coreg (carvedilol), used to treat high blood pressure, chronic heart ...

The first generic versions of GlaxoSmithKline’s cardiovascular agent Coreg – all 14 of them – have been approved by US regulators. The first generic versions of GlaxoSmithKline’s cardiovascular agent ...

Philadelphia, PA - GlaxoSmithKline announced that the FDA has approved carvedilol (Coreg®) for patients who have had an MI and who have left ventricular dysfunction. Carvedilol is the only ...

The US Food and Drug Administration has approved a label update for GlaxoSmithKline’s Coreg (carvedilol), meaning that the beta-blocker is now available to reduce the risk of suffering a heart attack.

TORONTO--(BUSINESS WIRE)--Feb. 26, 2004--Biovail Corporation (NYSE:BVF)(TSX:BVF) announced today it has acquired the rights to a novel formulation of eprosartan (Teveten(R)) and a formulation for an ...